Results 171 to 180 of about 3,772,562 (201)
Some of the next articles are maybe not open access.
Nursing Children and Young People, 2016
Brittle bone disease is also known as osteogenesis imperfecta, Vrolik syndrome and Lobstein syndrome. The condition is not gender specific and is present in all cultures. As the name of the disease suggests, the bones of people who have it are brittle and prone to fracture.
Doreen, Crawford, Annette, Dearmun
openaire +2 more sources
Brittle bone disease is also known as osteogenesis imperfecta, Vrolik syndrome and Lobstein syndrome. The condition is not gender specific and is present in all cultures. As the name of the disease suggests, the bones of people who have it are brittle and prone to fracture.
Doreen, Crawford, Annette, Dearmun
openaire +2 more sources
Current Treatment Options in Oncology, 2001
The major clinical manifestation of multiple myeloma results from osteolytic bone destruction. The only currently Food and Drug Administration-approved drug for the treatment of the bony complications of multiple myeloma is monthly intravenous pamidronate at a dose of 90 mg infused over 4 hours. Recent studies have shown the safety of 2-hour infusions.
openaire +2 more sources
The major clinical manifestation of multiple myeloma results from osteolytic bone destruction. The only currently Food and Drug Administration-approved drug for the treatment of the bony complications of multiple myeloma is monthly intravenous pamidronate at a dose of 90 mg infused over 4 hours. Recent studies have shown the safety of 2-hour infusions.
openaire +2 more sources
Bisphosphonates in bone diseases.
Pharmacy world & science : PWS, 1998Bisphosphonates are a class of drugs which are strongly attracted to the bone where they influence the calcium metabolism, mainly by inhibition of the osteoclast-mediated bone resorption. This property makes these compounds suited for the treatment of several diseases of the bone.
Sparidans, Rolf +2 more
openaire +2 more sources
2011
Abstract In 1876, Sir James Paget presented to the Royal Medical and Chirurgical Society of London an account of his experience with a previously unrecognized disease of the skeleton, which he termed osteitis deformans and has since born his name.
openaire +1 more source
Abstract In 1876, Sir James Paget presented to the Royal Medical and Chirurgical Society of London an account of his experience with a previously unrecognized disease of the skeleton, which he termed osteitis deformans and has since born his name.
openaire +1 more source
Retroviruses and Bone Diseases
Clinical Orthopaedics and Related Research, 1996In 1980, retroviruses were shown to be pathogenic to humans, and experimentation on animals involving retroviruses as causal agents of tumors and degenerative diseases of bone, brain, and lung gained interest. Osteopetrosis, which can be either inherited in rodents or retrovirally induced in cats, is exemplary.
openaire +2 more sources
Flavonoids in Bone Erosive Diseases: Perspectives in Osteoporosis Treatment
Trends in Endocrinology and Metabolism, 2021Angela de Luca +2 more
exaly